Enlivex Ltd. (NASDAQ:ENLV) IPO
IPO
Went public as BIO BLAST PHARMA LTD. Priced at US$11.00 a share on Jul 30, 2014.
- Price
- US$11.00 a share
- Shares offered
- 3,200,000 ordinary shares
- Offering size
- US$35.2 million
- Underwriters' option
- Up to 480,000 more shares
- Underwriters
- Oppenheimer & Co., Roth Capital Partners, BTIG · In the order on the cover
- Shares delivered
- On or about Aug 5, 2014
Steps
| Step | When |
|---|---|
| Filed publicly | Feb 7, 2014 |
| Amended 5 times | Newest Jul 25, 2014 |
| Shares registered with an exchange | Jul 28, 2014 |
| Declared effective by the SEC | Jul 30, 2014 |
| Final prospectus, with the price | Jul 31, 2014 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Jul 31, 2014 |
| CERTNAS · Nasdaq's certificate of listing | Jul 30, 2014 |
| EFFECT · Notice that a registration is effective | Jul 30, 2014 |
| CORRESP · Letter to the SEC | Jul 28, 2014 |
| CORRESP · Letter to the SEC | Jul 28, 2014 |
| 8-A12B · Registration of shares for listing on an exchange | Jul 28, 2014 |
| CORRESP · Letter to the SEC | Jul 25, 2014 |
| F-1/A · Registration statement, amended | Jul 25, 2014 |
| UPLOAD · Letter from the SEC | Jul 24, 2014 |
| F-1/A · Registration statement, amended | Jul 15, 2014 |
| F-1/A · Registration statement, amended | Jul 8, 2014 |
| F-1/A · Registration statement, amended | Apr 8, 2014 |
| CORRESP · Letter to the SEC | Apr 7, 2014 |
| UPLOAD · Letter from the SEC | Mar 27, 2014 |
| F-1/A · Registration statement, amended | Mar 17, 2014 |
| CORRESP · Letter to the SEC | Mar 14, 2014 |
| UPLOAD · Letter from the SEC | Mar 6, 2014 |
| F-1 · Registration statement | Feb 7, 2014 |
From the cover of the final prospectus (424B4) filed Jul 31, 2014